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Summary Multimodal management of lung cancer extending to chest wall and type of surgical
procedure to be performed are still debated. The aim of this retrospective analysis was to ana-
lyze the predictive factors of long-term survival after surgery, focusing on depth of infiltration,
type of surgical intervention and possible role of preoperative therapies, comparing survival
of these patients with that of a group of patients affected by a Pancoast tumour and surgical
treated in the same period.
Materials and methods: We reviewed records of 83 consecutive patients with NSCLC in stage
T3 (owing to direct extension to chest wall), who underwent surgical resection in our Thoracic
Surgery Unit between January 1994 and December 2003. Patients were classified in two groups:
pancoast tumours (PT) or chest wall extending tumours (CW): survival and prognostic factors
of each category were analyzed.
Results: In the CW group we had 68 patients: 45 were in stage IIB (pT3N0), 23 in stage IIIA
(pT3-N1-2). Histology revealed adenocarcinoma in 23 cases, squamous cell carcinoma in 34,
large cells anaplastic carcinoma in 8, adenosquamous carcinoma in 3. An involvement of chest
wall tissues beyond the endothoracic fascia was found in 21 patients, while in the remaining 47
the invasion of chest wall tissues was confined to the parietal pleura. An extrapleural dissection
was performed in 48 patients while combined pulmonary and chest wall en bloc resection was
required in 20 patients. Resection was incomplete in three cases. In the PT group we had 15
patients: 11 were in stage IIB and 4 in stage IIIA. Histological type was adenocarcinoma in 10
cases, squamous cell carcinoma in 4 and adenosquamous carcinoma in 1.
A univariate analysis performed in the CW group showed that survival was significantly
affected by nodal status, stage, extension of chest wall invasion, type of lung resection and
residual disease. In a multivariate analysis we found that nodal status, completeness of resec-
tion and extension of chest wall involvement maintained a significant prognostic value. There
was no difference between the survival curve of CW and PT group: considering the two subset
of CW patients, on the basis of depth of infiltration, survival of PT patients was significantly
better than that of CW patients with involvement of muscular tissues and ribs (p = 0.02).
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Conclusion: Nodal status, radical resection and depth of chest wall infiltration are the main
predictive factors affecting long-term survival, while surgical procedure does not impact on it if
margins of resection are free from disease. The better survival observed in PT patients let us to
hypothesize that an induction chemo-radiation therapy, as routinely administered to PT patients,
could have a potential benefit in survival of patients with CW tumour extending beyond parietal
pleura.
© 2006 Elsevier Ireland Ltd. All rights reserved.
1. Introduction
Surgery remains the cornerstone of treatment of lung can-
cer. The 5-year survival of patients treated for NSCLC varies
from 80% in T1N0M0 to less than 10% in bulky N2-3 disease
[1]. Invasion of chest wall is not rare, with a percentage
of 5—8% of all resected NSCLC; nowadays the prognostic
importance of this finding is controverse. Although neoplas-
tic invasion of chest wall cancer has never been considered
evidence of unresectability, early reports showed a very
low long-term survival [1—3]. Recent studies have shown
instead exceptional 5-year survivals, never reported before
in literatures [4,5]. The authors of these studies advocated
the en bloc chest wall resection in all patients with chest
wall involvement and rejected extra pleural dissection, also
in those patients with an isolated parietal pleural infiltra-
tion. However, although the objective of this policy should
chest wall.
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inlet. Mediastinoscopy, anterior mediastinotomy or trans-
bronchial biopsy were carried out in each case where CT-
scan showed evidence of N2 disease. Patients with recent
cardiac ischemia, congestive heart failure, unstable angina
pectoris, malignant arrhythmia and severe lung failure were
not candidate to surgery. Patients with impaired respira-
tory function (FEV1 < 60% predicted, DLCO< 60%, MVV < 50%)
underwent perfusion pulmonary scintigraphy and cardio-
pulmonary test.
All the 15 patients affected by PT received induction radi-
ation therapy (RT) associated with chemotherapy (CHT) in
the last 7 cases, according to the American College of Chest
Physician (ACCP) guidelines. No patients in the CW group
received induction therapy, except for one with histologi-
cally proven N2 disease. In all patients radical mediastinal
lymphadenectomy was performed. Resection was consid-
ered complete (R0) by demonstration of negative tissue
margins at pathological examination. Survival rates were
Themultivariate analysis was carried out with the same vari-
ables using the Cox’s proportional hazard test. The limit for
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rIn order to disclose a potential benefit of induction
hemo- and radiation-therapy in these patients, they were
ompared with a group of patients affected by pancoast
umour who systematically underwent a combined preoper-
tive treatment before surgery and were operated on during
he same period.
. Materials and methods
etween January 1994 and December 2004, 83 patients
ffected by NSCLC involving the chest wall underwent surgi-
al resection at the Thoracic Surgery Unit, University Hospi-
al of Siena, Italy. Sixty-eight out of these patients presented
chest wall invasion (CW), while 15 patients had a pancoast
umour (PT). Patients with metastatic cancer, occult pleu-
al dissemination, positive bronchial stump and SCLC were
xcluded from this study.
Preoperative work up consisted of: physical examina-
ion, routine blood tests, bronchoscopy and total body CT
can in all patients. Bone scintigraphy was also performed
n symptomatic patients or on those with high levels of
erum phosphate. All patients affected by PT received a
agnetic resonance (MR) in order to assess tumour exten-
ion to soft tissues or ribs and to exclude the infiltration
f nervous and/or vascular structures of the upper thoracictatistical significance was a p-value less than 0.05. In two
eries of patients the chi-square test was used to establish
he significance of different distribution of an event.
. Results
atients were divided into two groups: CW and PT group.
The CW group consisted of 68 patients (57 males and 11
emales), whose the mean age was 69 years (range 48—81).
n 17 of them (25%) cancer diagnosis was occasional. In the
est of them (51) the main symptoms were: chest pain in 29
ases (43%), cough in 12 (17%), dyspnoea in 5 (7%), fever in
(4%), asthenia and weight loss in 2 (3%). After surgery 45
atients (66%) were in pathological stage IIB and 17 (33%) in
tage IIIA. Out of them, 10 patients were T3N1 and 7 patients
3N2 (4 of N2 patients were unforseen at the clinical stag-
ng). The histology revealed: squamous cell carcinoma in 34
ases (50%), adenocarcinoma in 23 (34%), anaplastic large
ell carcinoma in 8 (12%), adenosquamous carcinoma in 3
4%). The operative procedures performed were: 45 lobec-
omies (66%), 18 pneumonectomies (26%), 3 segmentec-
omies (4%) and 2 wedge resections (3%). Sublobar resections
ere preferred in patients with severe impairment of respi-
atory function. An extrapleural dissection was carried outimprove the prognosis reducing local recurrences, many
series demonstrated that long-term survival is much more
impaired by distant metastases than by recurrences on chest
wall. Moreover, the possible role of induction and/or adju-
vant therapy in the improvement of prognosis is still debated
and no randomized trials have ever been reported until
now. The aim of our study is to investigate the possible fac-
tors that could affect long-term survival after surgery in an
homogenous group of patients affected by NSCLC invading
referred to 5-year follow-up from date of operation. Sur-
vival curves were computed using Kaplan—Meyer method
and compared with the log-rank test.
At the univariate analysis the prognostic factors tested
were: age, gender, hystology, extension of lung resection,
type of surgical procedure (en bloc versus extrapleural dis-
section), grade of chest wall invasion (parietal pleural versus
bone and muscular tissues) and completeness of resection.
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in 48 patients (70%) in which tumour was easily dissectable
from chest wall contact plane. In the remaining 20 patients,
ribs and/or intercostal muscles were affected and, there-
fore, an en bloc resection was mandatory. The mean number
of resected ribs was 2.6 (range 1—4) with a size of chest wall
resected between 4.7 and 5.9 cm. In three patients we found
microscopic residual disease (R1) at the resection margin.
Two patients had undergone en bloc chest wall resection
while one patient had an extrapleural mobilization of the
tumour (Table 1).
Among those patients who underwent en bloc resection
the chest wall involvement was antero-lateral in 12 patients
(60%) and posterior in 8 (40%).
As reported in literature [1] we performed reconstruction
of the chest wall in thin patients with large (>5 cm in great-
est length) and antero-lateral thoracectomies, in order to
prevent chest flail during breathing (scapula and muscolar
flap alone were considered sufficient for posterior defects).
Chest wall repair with prothesis was required in six patients
(29%); in the remaining 14 patients a muscle flap was used.
Average follow up was 27 months (range 8—144). The
30-day mortality was 4% (three patients). One patient died
intraoperatively of acute myocardial infarction; the other
two patients died of bronco-pleural fistula. Causes of death
at follow up were: distant relapse in 15 cases (22%), local
recurrence in 12 (17%), respiratory failure in 6 (9%), stroke in
2 (3%), pulmonary embolism in 2 (3%). Two patients received
neo-adjuvant chemotherapy, one patient radiation therapy
after developing local recurrence or distant metastases. The
overall survival rate in all CW patients was 37% (mean 59,
median 48, range 0—144 months).
In the subgroup of CW patients with isolated pleural
involvement we reported a 5-year survival rate of 43%; in
the subgroup with chest wall structures invasion 5-year sur-
vival rate was 8.7% (p = 0.003). Concerning nodal involve-
ment, 5-year survival rate was 42% in patients in stage IIB
and 17% in stage IIIA (p = 0.002). Considering the margins
of resection, none of the three patients with residual dis-
ease were alive after 5-year of follow up, while patients
with radical resection had a 5-year survival rate of 33%
(p = 0.0001). All five patients who had undergone sublo-
bar lung resection were dead after 9 months from date of
surgery (p = 0.001). Finally, survival rates after extrapleural
mobilization of tumour and after en bloc resection were 40
and 12%, respectively (p = 0.036). The survival curves of each
group and log-rank test values are shown in Figs. 1—5.
In order to assess their indipendent predictive value,
covariates were tested in a Cox-proportional hazard model
(Table 2). From multivariate analysis, depth of chest wall
invasion and nodal involvement resulted in two indepen-
dent adverse prognostic factors with respectively p = 0.011
and 0.033. Completeness of resection, which is a well
recognized factor worsening survival, failed to reach the
statistical significance because of the small number of
cases. Surgical procedures did not impact either in post-
operative mortality or in long-term survival. No differences
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s. pleon the mediastinum. All of them showed an histologically
proved N2 disease. Twenty-two patients received postoper-
ative treatment (CHT in 5 cases, RT in 12 and both in 5). Only
the three patients with R1 disease received RT as adjuvant
treatment, while the remaining 19 received RT and/or CHT
Table 1 Main demographic, clinical and pathological data o
CW pleural group
Age* 68.2
Gender (male/female) 37/10
Stage (IIB/IIIA) 29/18
Pulmonary resection
Lobectomy 30
Pneumonectomy 14
Segmentectomy 3
Wedge resection —
Hystology
ADK 13
Squamous cell K 23
Anaplastic 5
Other 6
Chest wall resection (yes/no) 1/46
Incomplete resection (R1)* —
Causes of death
Distant metastasis 12
Local recurrence 8
Other 4
Age (PT patients vs. others); incomplete resection (CW patients v
* Significative difference (p < 0.05).n terms of chest wall recurrences were found between
xtra pleural mobilization of the tumour and en bloc
esection.
Among the PT patients there were 15 patients (11
ales and 4 females) with mean age 61 (range 54—67). All
ulation
full thickness group PT group Total population
1 63.2* 67.9
1 13/2 70/13
5 11/4 56/27
13 58
2 20
— 3
— 2
10* 29
4* 38
— 8
1 8
2 15/— 34/49
1 3
5 20
2 14
1 11
ural); histology (PT patients vs. others).
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Fig. 1 Survival curves of the three groups.
Fig. 2 Survival curves in CW group according to stage.
patients complained for pain. Postoperative staging showed
13 patients (87%) in stage IIB and 2 (13%) in stage IIIA. Histol-
ogy revealed adenocarcinoma in 10 cases (67%), squamous
cell carcinoma in 4 (27%) and adenosquamous carcinoma in
1 (6%). Pulmonary resections were lobectomy in 13 cases
(87%), pneumonectomy in 1 case (6.6%) and sublobar resec-
tion in 1 case (6.6%).
In the group of PT patients 5-year survival rate was 49%
(mean survival time 50, median 39 months). No postopera-
tive fatal complications occurred. No predictive factors of
Fig. 3 Survival curves in CW group according to completeness
of resection.
Fig. 4 Survival curves according to type of lung resection.
survival were identified with statistical analysis, probably
because of the small number of cases.
Comparing the overall 5-year survival of all CW patients
with that of PT patients, we did not find any statistical
difference. However, patients of the CW group with ribs or
muscular invasion showed to have a significant lower survival
than patients of the PT group (p = 0.03) Moreover, 5-year sur-
vival of PT group was higher than that of CW subgroup with
Table 2 Multivariate analysis—–Cox regression (CW group)
Covariate Comparing factor Relative risk (95% CI) Significance
Age ≥vs. < 70 years 1.37 (0.57—3.29) p = 0.47
Gender Male vs. female 0.74 (0.24—2.29) p = 0.60
Lobectomy Yes vs. no 2.41 (0.62—9.33) p = 0.23
Pneumonectomy Yes vs. no 2.94 (0.7—12.2) p = 0.13
Pathological stage IIB vs. IIIA 0.38 (0.16—0.89) p = 0.027
Hystology Squamous cell carcinoma vs. others 0.38 (0.13—1.13) p = 0.08
Chest wall infiltration Muscle and ribs vs. parietal pleura 35.2 (1.4—868.4) p = 0.029
Surgical procedure Chest wall resection vs. extrapleural dissection 12.08 (0.56—257) p = 0.11
Margins of resection Positive vs. negative 1.1 (0.10—12.07) p = 0.92
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Fig. 5 Survival curves according to type of surgical procedure.
infiltration of chest wall structures (Fig. 1) and comparable
to that of CW group with isolated pleural involvement.
4. Discussion
Involvement of chest wall occurs from 3 to 8% of all surgically
treated NSCLC [1,6], and our series confirms this percentage
(6.3%). The management of this particular group of patients
remains a subject of interest especially for two reasons:
the factors that may influence the prognosis and the role of
induction and/or postoperative therapies in long-term sur-
vival. Chest wall invasion in NSCLC is no longer considered a
controindication for surgical resection [2], and durable sur-
vival can be achievedwith an acceptable operativemortality
[1,6]. However, many factors concur to impair the long-term
survival in these patients. In our study, standard survival
predictors (such as completeness of resection, lymph nodal
status, histology and extension of lung resection) were
analyzed along with depth of chest wall invasion and type of
resection (en bloc versus extrapleural), that are specific for
this group of patients. All predictors were firstly assessed
through a univariate analysis and then confirmed by a mul-
tivariate study. Lymphnodal infiltration and completeness
of resection appear to be the main survival predictors in the
univariate analysis: nodal status and not the completeness
of resection (probably for the small number of R1 patients)
maintained its significance in the multivariate analysis.
those with infiltration of the chest wall (p = 0.003). We also
found a better 5-year survival in patients who underwent
extrapleural resection than in those who received an en bloc
resection (p = 0.003). In our policy, in cases with minimal
parietal pleural involvement should be resected by an
extrapleural dissection without concomitant rib resection:
intraoperative histological exam of margins could be useful
for the surgeon. However, if in doubt, an en bloc resection
should be carried out. Facciolo advocated the en bloc chest
wall resection both in patients with a suspect of chest wall
involvement and in those with tumour confined in the pari-
etal pleura. With this approach, he obtained an extremely
high 5-year survival rate (79.1%) in patients with parietal
pleura invasion and in those with extrapleural chest wall
involvement (54%). This exceptional survival, never reported
before in literature for stage IIB, could justify an en bloc
resection beforehand. However, a higher incidence of mor-
tality and morbidity after chest wall resection is reported in
literature [8]. Although in our series the extrapleural dissec-
tion was associated to a better 5-year survival at the univari-
ate analysis, this significance was lost in the multivariate
analysis when extension of infiltration was introduced
among covariates. We can argue that the type of resection
has no impact on long-term survival, whereas depth of
infiltration is the most important independent prognostic
factor after the N status and the completeness of resection.
Although induction and/or adjuvant therapy could play a
role in CW patients, its usefulness is still debated. As far as
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literature and are universally accepted [2,3,7]. However,
the impact of these two factors on long-term survival is so
important that secondary factors like extension of infiltra-
tion, surgical strategy and postoperative treatment were
often difficult to define especially in a multivariate analysis.
In his series of 104 surgically resected patients, Chapelier
found that patients with a tumour infiltration confined to
the parietal pleura had a significantly better 5-year survival
than those with chest wall infiltration [3]. Deeper involve-
ment was advocated as a predictor of worse prognosis also
by Mischina et al. [9] and in a recent report by Facciolo et al.
[4], who found that depth of tumour invasion affected prog-
nosis in the sub-group of pN0 patients. In our series we found
a statistical difference in 5-year survival between patients
with a tumour infiltration confined to parietal pleura andostoperative radiation therapy is concerned, no random-
zed trials have ever been compared, and different conclu-
ions have been reported in various retrospective reviews.
ould has recently concluded that even though adjuvant
adiotherapy may reduce the local recurrence, it has no
mpact on long-term survival [10]. In our study no differ-
nces in survival have been observed between patients who
nderwent adjuvant treatment and those who did not. No
atients received preoperative radiation therapy except for
ne (in the mediastinum for lymphadenopaty). To assess the
ossible advantages of induction therapy in CW patients,
hese patients were compared with the group of PT patients
perated in the same period. Pancoast tumours are tradi-
ionally considered as a group of tumours with their own
haracteristics, especially for the particular symptomathol-
gy and surgical approach. However, they are included in
NM classification in stage T3 and, in our opinion, they can
e properly compared with CW tumours if no concomitant
ascular, nervous or vertebral infiltration (T4) is present.
he PT group showed a better 5-year survival than CW
ubgroup with muscular or rib invasion (p = 0.03) and sim-
lar those with the isolated pleural infiltration (p = n.s.).
he difference remained significative (p = 0.033) even after
xcluding perioperative deaths, presence of R1 disease and
ublobar pulmonary resections. The small number of cases
id not allow to find significative prognostic factors in a uni-
ariate and a multivariate analysis. However, the two groups
CW and PT) were homogeneous in terms of age, gender, pre-
perative work up, surgical management and pathological
tage. Histology revealed a higher percentage of adenocar-
inomas among PT patients. We can argue that preoperative
adiation therapy could improve the success of resection by
ircumscribing and reducing the infiltration of chest wall,
hus, allowing to achieve a final condition closer to isolated
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involvement of the parietal pleura. Since these conclusions
have been deduced from two similar but not equal groups
of patients, the potential benefit of induction therapy in CW
patients remains an hypothesis. Today, it represents, how-
ever, a stimulus to set up, in our Institution, a randomized
study which could provide objective data.
We conclude that the factors affecting long-term sur-
vival after complete resection are N-status and depth of
chest wall involvement. Consequently any effort must be
spent in achieving a preoperative accurate N-staging, avoid-
ing surgery in N2 patients before an induction chemotherapy.
The chest wall involvement should be assessed preopera-
tively by a videtoroacoscopic exploration as proposed by
Roviaro et al. [5] or, as in our experience, by a high res-
olution TC study. To conclude, since the detection of ribs
or muscular tumour invasion could be an indication to an
adjuvant chemo-radiation treatment, the role of CT scan
becomes crucial. Concerning chest wall extension, in addi-
tion to commonly used criteria (such as pleural contact area
and chest wall-tumour angle), thin-sectional CT scan with
specific software algorithms reconstruction can significantly
improve the accuracy of CT to the level reached by MRI, as
reported by Uhrmeister et al. [11].
The detection of an isolated parietal pleura infiltration by
CT scan is not crucial because those patients are candidated
for surgery as first therapeutic option if nodal involvement
has been excluded.
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